<?xml version="1.0" encoding="UTF-8"?>
<p id="p0005">The resistance of the pathogenic microorganisms including bacteria, fungi, virus and parasites to antimicrobial agents are increasing constantly due to the extensive use of antibiotics and natural selection of environment (
 <xref rid="b0215" ref-type="bibr">Sib et al., 2019</xref>). Recent years, the emergence of resistance to antibiotics increase the morbidity, mortality and challenging health care issues, and expanding all over the world (
 <xref rid="b0115" ref-type="bibr">Mekes et al., 2019</xref>). The continuous resistant against current antibiotics is a major reason for increase of multi drug resistance (MDR) effect in microbes (
 <xref rid="b0180" ref-type="bibr">Robert et al., 2018</xref>). Among these, MDR Gram negative bacterial (GNB) infections have played a major role worldwide in health care settings (
 <xref rid="b0155" ref-type="bibr">Rajivgandhi et al., 2018a</xref>). According to the WHO reports, carbapenem resistant GNB as the number 1 critical list including 
 <italic>Acinetobacter baumannii</italic>, 
 <italic>Klebseilla pneumoniae</italic>, 
 <italic>Pseudomonas aeruginosa</italic> and 
 <italic>Proteus mirabilis</italic> (
 <xref rid="b0260" ref-type="bibr">WHO, 2017</xref>). In 2019, the review of Antimicrobial resistance committee was announced that the carbapenem resistant GNB increase the number of death, it attributed to antimicrobial resistance could increase 1 million each year (
 <xref rid="b0235" ref-type="bibr">Teethaisong et al., 2019</xref>). Five fold increased death rate was reported recently in developing nations compared to developed nations.
</p>
